Lupin Ltd 05 Nov 2026 12:00 AM
Lupin Ltd consolidated sales down 5.25% on year in Q3FY2026, net profit fell 18.47%,
Lupin Ltd share price gained 0.15% to Rs 2015.0. The Company`s net profit dropped 18.47% to Rs 1155.3 crore, while revenue from operations eased by 5.25% to Rs 7785.52 crore in Q3FY26 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.82 lakh crore, easing 5.14%. It has improved by 2.03% over last one week and crept higher by 1.77% in last one month while the market capitalization of Lupin Ltd has inched up 0.85% and 14.61% in the same period respectively. Profit before tax (PBT) of Lupin Ltd stood at Rs 1579.6 crore in Q3 FY26, tumbling by 21.29% year-on-year, and nosediving by 21.70% quarter-on-quarter. EBITDA came in at Rs 1918 crore, dropping 14.82% YoY and plunging by 17.32% sequentially. Total expenses slightly declined by 0.18% to Rs 6268.75 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 1310.74 crore, slightly declining by 0.07% YoY, while employee benefits expense was at Rs 1423.58 crore, inching up 2.93% YoY. For the TTM ended FY26, revenue from operations jumped by 23.86% to Rs 27487.54 crore, while net profit soared by 61.98% to Rs 5355.47 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 529273% to Rs 8391.55 crore, and PBT witnessed a strong rise of 71.17% to Rs 6872.55 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 7334.5 crore in FY26, as against Rs 2999.94 crore in FY25. Lupin Ltd ticked higher by 0.84% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 7.38% during the same period.
Lupin Ltd 04 Nov 2026 12:00 AM
Lupin Ltd consolidated sales down 5.25% on year in Q3FY2026, net profit fell 18.47%,
Lupin Ltd share price ticked higher by 0.77% to Rs 2012.0. The Company`s net profit contracted by 18.47% to Rs 1155.3 crore, while revenue from operations softened by 5.25% to Rs 7785.52 crore in Q3FY26 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.73 lakh crore, rising 4.36%. It has improved by 1.84% over last one week and moved up slightly by 1.37% in last one month while the market capitalization of Lupin Ltd has marginally improved by 2.08% and 15.86% in the same period respectively. Profit before tax (PBT) of Lupin Ltd stood at Rs 1579.6 crore in Q3 FY26, plunging by 21.29% year-on-year, and tumbling by 21.70% quarter-on-quarter. EBITDA came in at Rs 1918 crore, dropping 14.82% YoY and nosediving by 17.32% sequentially. Total expenses marginally dropped 0.18% to Rs 6268.75 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 1310.74 crore, slightly declining by 0.07% YoY, while employee benefits expense was at Rs 1423.58 crore, ticking higher by 2.93% YoY. For the TTM ended FY26, revenue from operations witnessed a strong growth of 23.86% to Rs 27487.54 crore, while net profit jumped 61.98% to Rs 5355.47 crore, compared to previous TTM. EBITDA jumped by 529273% to Rs 8391.55 crore, and PBT soared 71.17% to Rs 6872.55 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 7334.5 crore in FY26, as against Rs 2999.94 crore in FY25. Lupin Ltd inched up 1.32% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 8.41% during the same period.
Lupin Ltd 04 Nov 2026 12:00 AM
Lupin Limited appoints Akhil Gupta as Independent Director for a five-year term,
Lupin Limited announced the appointment of Akhil Gupta as an Additional Director (Non-Executive, Independent) effective November 3, 2026, and as an Independent Director for a term of five consecutive years with effect from November 3, 2026, to November 2, 2031, subject to member approval. Gupta, a Chartered Accountant with extensive experience including a previous role as Vice Chairman of Bharti Enterprises Limited, currently serves as Chairman of 360 ONE WAM Limited, Coforge Limited, and Valuedrive Technologies Limited, among other positions.
Lupin Ltd 19 Oct 2026 12:00 AM
Lupin Limited to review quarterly and half-year financials at a board meeting,
Lupin Limited will hold a board meeting on Tuesday, November 03, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, according to a regulatory filing. The trading window for company insiders will be closed from Thursday, October 01, 2026, and will reopen on Friday, November 06, 2026.
Lupin Ltd 09 Oct 2026 12:00 AM
Lupin Limited reports certificate submission to SEBI regarding share transfer agent,
Lupin Limited, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, has forwarded a certificate received from MUFG Intime India Private Limited, formerly Link Intime India Private Limited, the company’s Registrar and Share Transfer Agent, for the quarter ended September 30, 2026.
Subscribe for our
newsletter
Open Account Now